Sign In
Buy AMGN
$345.60
+7.38 (+2.18%)
At Close: Jun 04, 2026
Dow 30 December Dogs Show 28 Pay Dividends And 1 "Safer" Buy
05:37pm, Wednesday, 04'th Dec 2024
Verizon is the only Dow Dog meeting the ideal of annual dividends from $1K invested exceeding its single share price. Five more Dow Dogs, including Cisco and Merck, are within 66% of meeting this idea
Amgen Inc. (AMGN) Annual Evercore ISI HealthCONx Healthcare Conference (Transcript)
02:27pm, Wednesday, 04'th Dec 2024
Amgen Inc. (NASDAQ:AMGN ) Annual Evercore ISI HealthCONx Healthcare Conference December 4, 2024 10:00 AM ET Company Participants Peter Griffith - Executive Vice President and Chief Financial Officer J
Amgen Stock Falls 12% in a Month: Should You Buy the Dip?
09:31am, Wednesday, 04'th Dec 2024
AMGN's reasonable valuation, an interesting pipeline and continued top-line growth are good enough reasons to stay invested in the stock for now.
Weight Loss Drug Wars Heat Up: Amgen Challenges Eli Lilly, Novo's Dominance
09:16am, Tuesday, 03'rd Dec 2024
The battle for the multibillion-dollar obesity market just got fiercer. Amgen Inc's AMGN new drug candidate, MariTide, reported promising results, helping patients shed around 20% of their body weight
Bargain Hunting In A Pricey Market: 2 High-Yield Dividend Picks That Have Me Hooked
07:30am, Tuesday, 03'rd Dec 2024
With markets surging, finding high-yield bargains can feel impossible. Yet, opportunities still exist for disciplined, value-focused investors. My strategy targets strong, dividend-paying businesses t
AMGEN TO PRESENT AT CITI'S 2024 GLOBAL HEALTHCARE CONFERENCE
04:00pm, Monday, 02'nd Dec 2024
THOUSAND OAKS, Calif. , Dec. 2, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at Citi's 2024 Global Healthcare Conference at 9:30 a.m.
This Stock Just Dropped by 12% in 1 Day: Should You Buy the Dip?
08:00am, Monday, 02'nd Dec 2024
The biotech industry can be volatile even for relatively large companies. Amgen (AMGN 1.00%), one of the more prominent names in the game, just reminded us all of that fact.
Amgen removed from US Conviction List at Goldman Sachs
05:41am, Monday, 02'nd Dec 2024
Goldman Sachs analysts removed Amgen from the firm's US Conviction List as part of its monthly update.
Down 12.3% at One Point in a Single Trading Session, Is Amgen Stock Still a Buy?
06:20am, Saturday, 30'th Nov 2024
The market didn't appreciate Amgen's (AMGN 1.00%) latest clinical data update, with the biopharma's shares falling more than 12% at one point on Nov. 26 from the previous day's close, though they reco
AMGEN TO PRESENT AT THE 7th ANNUAL EVERCORE HEALTHCONx CONFERENCE
04:30pm, Friday, 29'th Nov 2024
THOUSAND OAKS, Calif. , Nov. 29, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the 7th Annual Evercore HealthCONx Conference at 10:00 a.m.
Wide Trading Range For Amgen Stock Makes This Option Shine
02:06pm, Friday, 29'th Nov 2024
Even though Amgen is weak below the 200-day line, there's still a way to profit. The post Wide Trading Range For Amgen Stock Makes This Option Shine appeared first on Investor's Business Daily.
Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know
10:06am, Friday, 29'th Nov 2024
Amgen (AMGN) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Is Amgen Stock Still a Buy After an Unexpected Reveal of Data?
04:28am, Friday, 29'th Nov 2024
Shares of Amgen (AMGN 0.02%) are down by 6% in the last 30 days as I write this -- a larger-than-normal amount for a large pharma company's stock to fall, especially considering that the market rose n
AMGN Stock Down Despite Strong Data From Obesity Drug Study
04:00pm, Wednesday, 27'th Nov 2024
Data from a phase II study shows that AMGN's obesity drug MariTide leads to sustainable weight loss, robust improvements in cardiometabolic parameters and strong HbA1c reduction.
Amgen's Phase 2 Results Were Not Bad, Don't Let Mr. Market Fool You
01:06pm, Wednesday, 27'th Nov 2024
Amgen's MariTide shows up to 20% weight loss in Phase II, leaving room for improvement beyond 52 weeks, as weight loss did not plateau. GI side effects are a concern, but Amgen plans to address them t
